Heuszel Frank D
SEC insider (Form 3/4/5 filer). CIK 0001748704. Chief Executive Officer at IMPACT BIOMEDICAL INC. (IBO). 4 reported Form 4/5 transactions since Sep 2024; latest on Dec 5, 2024. Located in HOUSTON, TX.
Companies Heuszel Frank D has filed insider reports for
- IMPACT BIOMEDICAL INC. (IBO): Director, Officer, Chief Executive Officer
Heuszel Frank D
CIK: 0001748704
Transaction Breakdown
Open Market Buys (P)4 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IBO
IMPACT BIOMEDICAL INC.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Dec 5, 2024IBO
IMPACT BIOMEDICAL INC.
PurchaseDirect500 shares at avg. $2.26$1K - Nov 27, 2024IBO
IMPACT BIOMEDICAL INC.
PurchaseDirect500 shares at avg. $2.61$1K - Nov 26, 2024IBO
IMPACT BIOMEDICAL INC.
PurchaseDirect550 shares at avg. $2.63$1K - Nov 26, 2024IBO
IMPACT BIOMEDICAL INC.
PurchaseDirect500 shares at avg. $2.59$1K
1-4 of 4 transactions